Medications for Gastroenteropancreatic Neuroendocrine Tumor

2 results

  • lanreotide acetate

    (LANREOTIDE ACETATE)
    Cipla USA Inc.
    Lanreotide Injection is indicated for the long-term treatment of acromegaly in patients not responding to surgery/radiotherapy, and for unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival. It also treats adults with carcinoid syndrome, reducing the need for short-acting somatostatin analogs.

  • lutathera

    (Lutetium Lu 177 dotatate)
    Advanced Accelerator Applications USA, Inc
    LUTATHERA is indicated for treating adult and pediatric patients aged 12 and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), encompassing foregut, midgut, and hindgut tumors.